General

Pradaxa, manufactured by Boehringer Ingelheim Pharmaceuticals Inc. is an anticoagulant prescribed to prevent blood clots and reduce the risk of stroke. The drug which was…

On June 8, 2018, plaintiffs and defendants in the federal litigation over kidney injuries linked to Proton Pump Inhibitors (PPIs) submitted proposals to the Court for the first bellwether scheduling order and trial date. After an…

Los Angeles Superior Judge Stephen Moloney announced a mistrial in Johnson & Johnson's talcum powder lawsuit alleging asbestos in the talc developed mesothelioma in the…

According to a case management order dated May 29, 2018, the federal bellwether trials for Atrium Medical Corp.’s C-Qur hernia mesh will begin on February 19, 2020. A…

Xarelto:

Lawsuits against the anti-clotting drug Xarelto, alleged to cause internal bleeding and infection in patients, are piling against…

U.S. District Judge Freda L. Wolfson dismissed 95 Plavix lawsuits against Bristol-Myers Squibb and Sanofi-Aventis as the patients involved in the MDL failed to respond to…

Birmingham Hip Resurfacing (BHR) System manufacturer Smith & Nephew PLC appealed to a Maryland federal court to dismiss 55 claims from the federal MDL stating the statute of limitation has expired on those cases.

Each patient…

An Arizona federal judge rejected C.R.Bard's appeal for a new trial and judgment in a $3.6 million verdict awarded to a woman, who suffered complications due to fracture and migration of the G2…

According to a response to an order submitted on June 11, the parties of the Proton Pump Inhibitor (PPI) lawsuits have reached an agreement to coordinate pretrial proceedings between Delaware state court and New Jersey federal court.…

In a case management order submitted on June 13, the U.S. District Judge Milazzo proposed a bellwether schedule for five Taxotere hair loss lawsuits slated to begin on May…